Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation

[1]  H. Pollard.  The Developing Genome: An Introduction to Behavioral Epigenetics , 2018, Psychiatry.

[2]  Xiaowei Chen,et al.  Transcriptional Selectivity of Epigenetic Therapy in Cancer. , 2017, Cancer research.

[3]  S. Duan,et al.  Elevated DRD4 promoter methylation increases the risk of Alzheimer's disease in males. , 2016, Molecular medicine reports.

[4]  D. Bennett,et al.  The epigenome in Alzheimer’s disease: current state and approaches for a new path to gene discovery and understanding disease mechanism , 2016, Acta Neuropathologica.

[5]  Shunichiro Shinagawa,et al.  DNA methylation in the NCAPH2/LMF2 promoter region is associated with hippocampal atrophy in Alzheimer’s disease and amnesic mild cognitive impairment patients , 2016, Neuroscience Letters.

[6]  B. de Strooper,et al.  miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain , 2016, EMBO molecular medicine.

[7]  Guowei Huang,et al.  Folic acid attenuates the effects of amyloid β oligomers on DNA methylation in neuronal cells , 2016, European Journal of Nutrition.

[8]  P. Nelson,et al.  Non-random distribution of methyl-CpG sites and non-CpG methylation in the human rDNA promoter identified by next generation bisulfite sequencing. , 2016, Gene.

[9]  P. Jin,et al.  Genome-wide alteration of 5-hydroxymenthylcytosine in a mouse model of Alzheimer’s disease , 2016, BMC Genomics.

[10]  A. Camozzato,et al.  The synergistic risk effect of apolipoprotein ε4 and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) haplotype for Alzheimer’s disease , 2016, Molecular Biology Reports.

[11]  L. Lam,et al.  Association of gene expression and methylation of UQCRC1 to the predisposition of Alzheimer's disease in a Chinese population. , 2016, Journal of psychiatric research.

[12]  H. Soininen,et al.  Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology , 2016, Molecular Psychiatry.

[13]  Alison I. Bernstein,et al.  5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity. , 2016, Human molecular genetics.

[14]  Kenneth H. Pollock,et al.  Community Attitudes and Practices of Urban Residents Regarding Predation by Pet Cats on Wildlife: An International Comparison , 2016, PloS one.

[15]  D. Mari,et al.  Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease , 2016, Journal of the Neurological Sciences.

[16]  M. Barrachina,et al.  Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease-Related Pathology and in Parkinson Disease. , 2016, The American journal of pathology.

[17]  A. Sharp,et al.  Genome-wide12 DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer’s disease , 2016, Genome Medicine.

[18]  Shunichiro Shinagawa,et al.  Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment , 2016, PloS one.

[19]  Matthew D. Schultz,et al.  Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns , 2016, Translational psychiatry.

[20]  T. P. Centeno,et al.  DNA methylation changes in plasticity genes accompany the formation and maintenance of memory , 2015, Nature Neuroscience.

[21]  J. Sweatt,et al.  Tet1 oxidase regulates neuronal gene transcription, active DNA hydroxymethylation, object location memory, and threat recognition memory , 2015, Neuroepigenetics.

[22]  S. Leurgans,et al.  Association of DNA methylation in the brain with age in older persons is confounded by common neuropathologies. , 2015, The international journal of biochemistry & cell biology.

[23]  E. Porcellini,et al.  Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients , 2015, Neuroscience Letters.

[24]  J. Wong,et al.  Oxidative DNA demethylation mediated by Tet enzymes , 2015 .

[25]  F. Tang,et al.  A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging , 2015, Science.

[26]  Jennifer S. Woo,et al.  The cerebellum ages slowly according to the epigenetic clock , 2015, Aging.

[27]  J. Sweatt,et al.  DNA methylation regulates neurophysiological spatial representation in memory formation , 2015, Neuroepigenetics.

[28]  Haiyuan Yu,et al.  Trimethylation of Lys36 on H3 restricts gene expression change during aging and impacts life span , 2015, Genes & development.

[29]  Daniela Mari,et al.  Global changes in DNA methylation in Alzheimer’s disease peripheral blood mononuclear cells , 2015, Brain, Behavior, and Immunity.

[30]  D. Moore.  The Developing Genome: An Introduction to Behavioral Epigenetics , 2015 .

[31]  S. Sorbi,et al.  Epigenetic modifications in Alzheimer's disease: cause or effect? , 2014, Journal of Alzheimer's disease : JAD.

[32]  J. Jia,et al.  Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer’s disease , 2014, Acta Neurologica Belgica.

[33]  D. Bennett,et al.  Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease , 2014, Nature Neuroscience.

[34]  Manolis Kellis,et al.  Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014 .

[35]  Andre Fischer,et al.  Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue? , 2014, Neuropharmacology.

[36]  Peter D. Adams,et al.  Senescent cells harbour features of the cancer epigenome , 2013, Nature Cell Biology.

[37]  Stephen Todd,et al.  Survival in dementia and predictors of mortality: a review , 2013, International journal of geriatric psychiatry.

[38]  T. Hensch,et al.  DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease , 2013, Brain : a journal of neurology.

[39]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[40]  L. Tan,et al.  Epigenetic mechanisms in Alzheimer's disease: Implications for pathogenesis and therapy , 2013, Ageing Research Reviews.

[41]  G. Andria,et al.  Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. , 2013, Molecular genetics and metabolism.

[42]  Tom H. Cheung,et al.  Chromatin Modifications as Determinants of Muscle Stem Cell Quiescence and Chronological Aging , 2013, Cell reports.

[43]  Mahsa Jalili.  Send Orders of Reprints at Reprints@benthamscience.net Effect of Diet and Nutrients on Molecular Mechanism of Gene Expression Mediated by Nuclear Receptor and Epigenetic Modulation , 2022 .

[44]  Elizabeth Head,et al.  Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human down syndrome brains. , 2013, The Journal of Biological Chemistry.

[45]  T. Ideker,et al.  Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.

[46]  J. Mill,et al.  CNP and DPYSL2 mRNA expression and promoter methylation levels in brain of Alzheimer's disease patients. , 2012, Journal of Alzheimer's disease : JAD.

[47]  H. Manev,et al.  Effect of aging on 5-hydroxymethylcytosine in brain mitochondria , 2012, Neurobiology of Aging.

[48]  J. Mill,et al.  SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer’s Disease , 2012, Neurochemistry International.

[49]  Peng Jin,et al.  Dynamics of DNA methylation in aging and Alzheimer's disease. , 2012, DNA and cell biology.

[50]  J. Mill,et al.  Analysis of SNAP25 mRNA expression and promoter DNA methylation in brain areas of Alzheimer’s Disease patients , 2012, Neuroscience.

[51]  J. Teng,et al.  MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1 , 2012, Brain Research Bulletin.

[52]  A. Georgakopoulos,et al.  Cellular mechanisms of γ-secretase substrate selection, processing and toxicity , 2012, Progress in Neurobiology.

[53]  A. Fagan,et al.  Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. , 2012, Human molecular genetics.

[54]  S. Rapoport,et al.  Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients , 2012, Translational Psychiatry.

[55]  Y. Shi,et al.  Tet family proteins and 5-hydroxymethylcytosine in development and disease , 2012, Development.

[56]  F. Coppedè,et al.  Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer's disease patients and healthy controls. , 2012, Antioxidants & redox signaling.

[57]  Hao Wu,et al.  Regulation and function of mammalian DNA methylation patterns: a genomic perspective. , 2012, Briefings in functional genomics.

[58]  I. Pérez-Otaño,et al.  Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease , 2012, Hippocampus.

[59]  P. Kenny,et al.  MicroRNAs in neuronal function and dysfunction , 2012, Trends in Neurosciences.

[60]  S. Hébert,et al.  MicroRNAs in Alzheimer's disease , 2012, Neurobiology of Disease.

[61]  G. Passarino,et al.  Epidemiological, genetic and epigenetic aspects of the research on healthy ageing and longevity , 2012, Immunity & Ageing.

[62]  C. Bountra,et al.  Epigenetic protein families: a new frontier for drug discovery , 2012, Nature Reviews Drug Discovery.

[63]  S. Gandy,et al.  Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease , 2012, BMC Medicine.

[64]  H. Manev,et al.  Mitochondrial DNA: a blind spot in neuroepigenetics , 2012, Biomolecular concepts.

[65]  K. Sutherland,et al.  The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T‐cell lymphoma patients , 2012, American journal of hematology.

[66]  Xiaozhong Peng,et al.  MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice , 2012, Neurobiology of Aging.

[67]  Wei Chen,et al.  The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease. , 2012, Toxicology letters.

[68]  J. Kleinman,et al.  DNA methylation signatures in development and aging of the human prefrontal cortex. , 2012, American journal of human genetics.

[69]  E. Junn,et al.  MicroRNAs in neurodegenerative diseases and their therapeutic potential. , 2012, Pharmacology & therapeutics.

[70]  G. Rabinovich,et al.  Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression , 2012, Journal of leukocyte biology.

[71]  L. Tan,et al.  The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy , 2012, Molecular Neurobiology.

[72]  L. Martin,et al.  Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation , 2011, The Journal of Neuroscience.

[73]  P. Falkai,et al.  microRNA‐34c is a novel target to treat dementias , 2011, The EMBO journal.

[74]  T. Maeda,et al.  Effect of Vitamin E Administration on the Elevated Oxygen Stress and the Telomeric and Subtelomeric Status in Alzheimer’s Disease , 2011, Gerontology.

[75]  A. Baccarelli,et al.  DNA methylation in repetitive elements and Alzheimer disease , 2011, Brain, Behavior, and Immunity.

[76]  Michael J Owen,et al.  Alzheimer's disease genetics: current knowledge and future challenges , 2011, International journal of geriatric psychiatry.

[77]  P. Nelson,et al.  Epigenetic Silencing of Nucleolar rRNA Genes in Alzheimer's Disease , 2011, PloS one.

[78]  R. Stilling,et al.  The role of histone acetylation in age-associated memory impairment and Alzheimer’s disease , 2011, Neurobiology of Learning and Memory.

[79]  J. Rogers,et al.  Epigenetic mechanisms in Alzheimer's disease , 2011, Neurobiology of Aging.

[80]  David M Holtzman,et al.  Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance , 2011, Science Translational Medicine.

[81]  J. David Sweatt,et al.  Epigenetic Mechanisms in Cognition , 2011, Neuron.

[82]  X. Gidrol,et al.  Pre-microRNA and Mature microRNA in Human Mitochondria , 2011, PloS one.

[83]  D. Hwang,et al.  Shot-gun proteomic analysis of mitochondrial D-loop DNA binding proteins: identification of mitochondrial histones. , 2011, Molecular bioSystems.

[84]  Albert Hofman,et al.  Plasma clusterin and the risk of Alzheimer disease. , 2011, JAMA.

[85]  S. Philipsen,et al.  Functional and sequence analysis of human neuroglobin gene promoter region. , 2011, Biochimica et biophysica acta.

[86]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[87]  Anne Corbett,et al.  Alzheimer's disease , 2011, The Lancet.

[88]  Shirley M. Taylor,et al.  DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria , 2011, Proceedings of the National Academy of Sciences.

[89]  P. Jin,et al.  Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine , 2011, Nature Biotechnology.

[90]  L. Tsai,et al.  Targeting the correct HDAC(s) to treat cognitive disorders. , 2010, Trends in pharmacological sciences.

[91]  Joseph Rogers,et al.  Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation , 2010, Neurobiology of Aging.

[92]  B. Winblad,et al.  A DNA Methylation Study of the Amyloid Precursor Protein Gene in Several Brain Regions from Patients with Familial Alzheimer Disease , 2010, Journal of neurogenetics.

[93]  B. Doble,et al.  Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci* , 2010, The Journal of Biological Chemistry.

[94]  Peter A. Jones,et al.  Epigenetic Modifications as Therapeutic Targets , 2010, Nature Biotechnology.

[95]  P. Marks.  The clinical development of histone deacetylase inhibitors as targeted anticancer drugs , 2010, Expert opinion on investigational drugs.

[96]  Francesca Tuorto,et al.  RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage. , 2010, Genes & development.

[97]  Susan M Resnick,et al.  Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. , 2010, Archives of general psychiatry.

[98]  T. Preiss,et al.  Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β , 2010, PloS one.

[99]  A. Marini,et al.  Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons , 2010, Annals of the New York Academy of Sciences.

[100]  S. Stahl.  Fooling Mother Nature: Epigenetics and Novel Treatments for Psychiatric Disorders , 2010, CNS Spectrums.

[101]  T. Suuronen,et al.  Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease , 2010, Neuroscience Letters.

[102]  Lennart Opitz,et al.  Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice , 2010, Science.

[103]  Z. Weng,et al.  Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex , 2010, Proceedings of the National Academy of Sciences.

[104]  S. Stahl.  Methylated Spirits: Epigenetic Hypotheses of Psychiatric Disorders , 2010, CNS Spectrums.

[105]  M. Tsuda,et al.  Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2'-deoxycytidine in Neuro-2a cells. , 2010, Biochemical and biophysical research communications.

[106]  Courtney A Miller,et al.  Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease , 2010, Neuropsychopharmacology.

[107]  M. Fasshauer,et al.  Amyloid precursor protein expression is induced by tumor necrosis factor α in 3T3‐L1 adipocytes , 2009, Journal of cellular biochemistry.

[108]  Lucinda K. Southworth,et al.  Aging Mice Show a Decreasing Correlation of Gene Expression within Genetic Modules , 2009, PLoS genetics.

[109]  A. Fischer,et al.  The epigenetic bottleneck of neurodegenerative and psychiatric diseases , 2009, Biological chemistry.

[110]  M. Barrachina,et al.  DNA Methylation of Alzheimer Disease and Tauopathy-Related Genes in Postmortem Brain , 2009, Journal of neuropathology and experimental neurology.

[111]  F. Coppedè,et al.  Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. , 2009, Mutation research.

[112]  Yu-hsuan Chen,et al.  S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters. , 2009, Neurotoxicology.

[113]  W-S Xu,et al.  Histone deacetylase inhibitors: Potential in cancer therapy , 2009, Journal of cellular biochemistry.

[114]  B. Ray,et al.  The “LEARn” (Latent Early-life Associated Regulation) model may explain the etiology of sporadic cases of Alzheimer's disease , 2009, Alzheimer's & Dementia.

[115]  N. Heintz,et al.  The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain , 2009, Science.

[116]  M Schwaiger,et al.  Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease , 2009, Neurology.

[117]  A. García-Osta,et al.  Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model , 2009, Neuropsychopharmacology.

[118]  F. Pasquier,et al.  Is the ornithine transcarbamylase gene a genetic determinant of Alzheimer’s disease? , 2009, Neuroscience Letters.

[119]  Kunlin Chen,et al.  The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells. , 2009, Biochemical and biophysical research communications.

[120]  A. Guimarães,et al.  Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[121]  F. Sun,et al.  Caspase inhibition attenuates accumulation of β-amyloid by reducing β-secretase production and activity in rat brains after stroke , 2008, Neurobiology of Disease.

[122]  Hong Qing,et al.  Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models , 2008, The Journal of Experimental Medicine.

[123]  F. LaFerla,et al.  Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau , 2008, The Journal of Neuroscience.

[124]  Dao-Wen Wang,et al.  Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus , 2008, Neurobiology of Aging.

[125]  Ming Wang,et al.  S-adenosyl-L-methionine improves impaired hippocampal long-term potentiation and water maze performance induced by developmental lead exposure in rats. , 2008, European journal of pharmacology.

[126]  M. Tsao,et al.  Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma—Epigenetic downregulation of caspases , 2008, International journal of cancer.

[127]  T. Tammela,et al.  Clusterin is epigenetically regulated in prostate cancer , 2008, International journal of cancer.

[128]  P. Dolan,et al.  Histone deacetylase 6 interacts with the microtubule‐associated protein tau , 2008, Journal of neurochemistry.

[129]  H. Tanila,et al.  Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A , 2008, Neurobiology of Disease.

[130]  A. Wilson.  Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. , 2008, Journal of periodontology.

[131]  Sun-Chong Wang,et al.  Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease , 2008, PloS one.

[132]  A. Bird,et al.  DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.

[133]  Jan-Gowth Chang,et al.  A pilot study for circadian gene disturbance in dementia patients , 2008, Neuroscience Letters.

[134]  F. D’Anselmi,et al.  B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-β deposition in mice , 2008, Molecular and Cellular Neuroscience.

[135]  K. Jin,et al.  Neuroglobin attenuates β-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo , 2007, Proceedings of the National Academy of Sciences.

[136]  Dong Hou Kim,et al.  Methotrexate decreases PP2A methylation and increases tau phosphorylation in neuron. , 2007, Biochemical and biophysical research communications.

[137]  W. Sippl,et al.  Structure–Activity Studies on Suramin Analogues as Inhibitors of NAD+‐Dependent Histone Deacetylases (Sirtuins) , 2007, ChemMedChem.

[138]  K. Engeland,et al.  Cell cycle‐dependent transcription of cyclin B2 is influenced by DNA methylation but is independent of methylation in the CDE and CHR elements , 2007, The FEBS journal.

[139]  R. Jaenisch,et al.  DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons , 2007, PloS one.

[140]  Joel M Stein,et al.  Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation , 2007, The Journal of Neuroscience.

[141]  T. Suuronen,et al.  Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells. , 2007, Biochemical and biophysical research communications.

[142]  R. Diaz-Arrastia,et al.  Protein Phosphatase 2A Methyltransferase Links Homocysteine Metabolism with Tau and Amyloid Precursor Protein Regulation , 2007, The Journal of Neuroscience.

[143]  W. Jagust,et al.  Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. , 2007, The American journal of clinical nutrition.

[144]  J. Jolles,et al.  Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial , 2007, The Lancet.

[145]  F. D’Anselmi,et al.  Corrigendum to “S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production” [Mol. Cell. Neurosci. 28 (2005) 195–204] , 2006, Molecular and Cellular Neuroscience.

[146]  A. Levey,et al.  The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments , 2006, The Journal of Neuroscience.

[147]  U. Werneke,et al.  Complementary medicines in psychiatry , 2006, British Journal of Psychiatry.

[148]  S. Kyrylenko,et al.  Induction of clusterin/apoJ expression by histone deacetylase inhibitors in neural cells , 2005, Neurochemistry International.

[149]  W. Markesbery,et al.  Ribosome Dysfunction Is an Early Event in Alzheimer's Disease , 2005, The Journal of Neuroscience.

[150]  Woo Ho Kim,et al.  Loss of caspase-1 gene expression in human gastric carcinomas and cell lines. , 2005, International journal of oncology.

[151]  E. Bertini,et al.  Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients , 2005, European Journal of Human Genetics.

[152]  F. D’Anselmi,et al.  S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production , 2005, Molecular and Cellular Neuroscience.

[153]  F. Liu,et al.  Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. , 2004, Biochemistry.

[154]  C. Fuke,et al.  Age Related Changes in 5‐methylcytosine Content in Human Peripheral Leukocytes and Placentas: an HPLC‐based Study , 2004, Annals of human genetics.

[155]  Jorge Cortes,et al.  Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies. , 2004, Blood.

[156]  E. Masliah,et al.  Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function , 2004, Journal of Neural Transmission.

[157]  Raphael Kopan.  Faculty Opinions recommendation of Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. , 2003 .

[158]  Andrea Fuso,et al.  Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease? , 2003, FEBS letters.

[159]  Stuart L Schreiber,et al.  Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[160]  I. Grundke‐Iqbal,et al.  Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[161]  H. Tohgi,et al.  The methylation status of cytosines in a τ gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex , 1999, Neuroscience Letters.

[162]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[163]  H. Tohgi,et al.  Reduction with age in methylcytosine in the promoter region −224∼−101 of the amyloid precursor protein gene in autopsy human cortex , 1999 .

[164]  Peter A. Jones,et al.  The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53 , 1998, Molecular and Cellular Biology.

[165]  E. Mandelkow,et al.  Tau in Alzheimer's disease. , 1998, Trends in cell biology.

[166]  T. Suuronen,et al.  Neuronal apoptosis induced by histone deacetylase inhibitors. , 1998, Brain research. Molecular brain research.

[167]  S. Lovestone,et al.  The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. , 1997, Neuroscience.

[168]  K. Bélanger,et al.  Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer. , 1997, Anti-cancer drugs.

[169]  S. Kish,et al.  Brain S‐Adenosylmethionine Levels Are Severely Decreased in Alzheimer's Disease , 1996, Journal of neurochemistry.

[170]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[171]  B. Toone,et al.  Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[172]  V. Wilson,et al.  Genomic 5-methyldeoxycytidine decreases with age. , 1987, The Journal of biological chemistry.

[173]  S. Goldstein,et al.  Mitochondrial DNA in mortal and immortal human cells. Genome number, integrity, and methylation. , 1983, The Journal of biological chemistry.

[174]  A. Riggs,et al.  DNA methylation and gene function. , 1980, Science.

[175]  B. F. Vaniushin,et al.  [DNA-methylase activities from animal mitochondria and nuclei: different specificity of DNA methylation]. , 1976, Biokhimiia.

[176]  M. M. Nass.  Differential methylation of mitochondrial and nuclear DNA in cultured mouse, hamster and virus-transformed hamster cells. In vivo and in vitro methylation. , 1973, Journal of molecular biology.

[177]  C. Rollán.  Epigenetics: An overview , 2014 .

[178]  Samira Lakhal,et al.  RNAi Therapeutic Delivery by Exosomes , 2013 .

[179]  Howard Hu,et al.  Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. , 2012, Journal of Alzheimer's disease : JAD.

[180]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[181]  A. Fuso,et al.  B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A. , 2010, Journal of Alzheimer's disease : JAD.

[182]  T. Groen.  DNA Methylation and Alzheimer’s Disease , 2010 .

[183]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[184]  F. Pasquier,et al.  Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease , 2009, Molecular Psychiatry.

[185]  P. Bertolucci,et al.  Promoter methylation analysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.

[186]  R. Obeid,et al.  The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases , 2007, Clinical chemistry and laboratory medicine.

[187]  I. Pogribny,et al.  Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. , 2003, Carcinogenesis.

[188]  I. Pogribny,et al.  Studies of methionine cycle intermediates (SAM, SAH), DNA methylation and the impact of folate deficiency on tumor numbers in Min mice. , 2002, Carcinogenesis.

[189]  M. Béné,et al.  CSF-folate levels are decreased in late-onset AD patients , 2001, Journal of Neural Transmission.

[190]  V. Klimenko,et al.  The 5-methylcytosine in DNA of rats. Tissue and age specificity and the changes induced by hydrocortisone and other agents. , 1973, Gerontologia.

[191]  V. Klimenko,et al.  The 5-Methylcytosine in DNA of Rats , 1973 .